On-Demand ICS + FABA Combinations in 6–11-Year-Old Children

Simple item page
dc.article.number7270
dc.catalogadorgrr
dc.contributor.authorNavarrete-Rodriguez, E.M.
dc.contributor.authorDel-Rio-Navarro, B.E.
dc.contributor.authorLarenas-Linnemann, D.
dc.contributor.authorCastro Rodriguez, José Antonio
dc.date.accessioned2024-01-24T23:50:37Z
dc.date.available2024-01-24T23:50:37Z
dc.date.issued2023
dc.description.abstractIn recent years, some new concepts have been added to asthma treatment such as “anti-inflammatory reliever” (β2-agonist use associated to an inhaled corticosteroid (ICS) as a reliever treatment) that combines the benefits of both therapies and provides short- and long-term benefits for treatment in asthma patients. Robust evidence has been presented in patients over 12 years, and the main changes in the international guidelines for asthma treatment were originally made in this age group. However, a few suggestions have been added to treatments in younger patients, in part because of the scarce evidence that exists in this group. We aim to analyze the information regarding the utilization of ICS + fast-acting beta-agonist (FABA) combination in children between 6 and 11 years. Although up until today only three published trials exist (two studies use beclomethasone + albuterol and one study uses budesonide + formoterol), they provide significant information on the benefits of ICS + FABA use in this population.
dc.fechaingreso.objetodigital2024-01-24
dc.format.extent16 páginas
dc.fuente.origenORCID-ene24
dc.identifier.doi10.3390/jcm12237270
dc.identifier.issn2077-0383
dc.identifier.pubmedid38068322
dc.identifier.scopusidSCOPUS_ID:85179352147
dc.identifier.urihttps://doi.org/10.3390/jcm12237270
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/80951
dc.identifier.wosidWOS:001116793800001
dc.information.autorucEscuela de Medicina; Castro Rodriguez, José Antonio; 0000-0002-0708-4281; 113247
dc.issue.numero23
dc.language.isoen
dc.nota.accesoContenido completo
dc.revistaJournal of Clinical Medicine
dc.rightsacceso abierto
dc.rights.licenseAtribución 4.0 Internacional (CC BY 4.0)
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/deed.es
dc.subjectAnti-inflammatory rescue therapy
dc.subjectAsthma treatment
dc.subjectFast-acting beta-agonist
dc.subjectSchool children
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleOn-Demand ICS + FABA Combinations in 6–11-Year-Old Children
dc.typeartículo de revisión.
dc.volumen12
sipa.codpersvinculados113247
sipa.trazabilidadORCID;2024-01-15
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
jcm-12-07270-v2.pdf
Size:
1.42 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas